blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3534943

EP3534943 - REPLICATION-DEFICIENT ARENAVIRUS PARTICLES AND TRI-SEGMENTED ARENAVIRUS PARTICLES AS CANCER VACCINES [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  07.07.2020
Database last updated on 28.09.2024
FormerRequest for examination was made
Status updated on  09.08.2019
FormerThe international publication has been made
Status updated on  11.05.2018
Formerunknown
Status updated on  05.12.2017
Most recent event   Tooltip24.11.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Hookipa Biotech GmbH
Helmut-Qualtinger-Gasse 2
1030 Wien / AT
[2019/37]
Inventor(s)01 / SCHMIDT, Sarah
Eroicagasse 7/5/2
1190 Vienna / AT
02 / ORLINGER, Klaus
Schätzgasse 4/1
1190 Vienna / AT
03 / RING, Sandra Stephanie
Münchner Str. 101
85774 Unterföhring / DE
04 / FLATZ, Lukas Roland
Falkenstrasse 6
8400 Winterthur / CH
[N/P]
Former [2019/37]01 / SCHMIDT, Sarah
Seuttergasse 44/24
1130 Vienna / AT
02 / ORLINGER, Klaus
Schätzgasse 4/1
1190 Vienna / AT
03 / RING, Sandra Stephanie
Münchner Str. 101
85774 Unterföhring / DE
04 / FLATZ, Lukas Roland
Falkenstrasse 6
8400 Winterthur / CH
Representative(s)Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte
Prinzregentenstrasse 11
80538 München / DE
[2019/37]
Application number, filing date17804079.603.11.2017
[2019/37]
WO2017EP78149
Priority number, dateUS201662417865P04.11.2016         Original published format: US 201662417865 P
US201662417891P04.11.2016         Original published format: US 201662417891 P
[2019/37]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2018083220
Date:11.05.2018
Language:EN
[2018/19]
Type: A2 Application without search report 
No.:EP3534943
Date:11.09.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 11.05.2018 takes the place of the publication of the European patent application.
[2019/37]
Search report(s)International search report - published on:EP13.12.2018
ClassificationIPC:A61K39/12
[2019/37]
CPC:
A61K39/12 (EP,US); A61K39/001156 (EP,US); A61K39/001192 (EP,US);
A61P31/00 (US); A61P35/00 (EP,US); A61K2039/572 (EP,US);
A61K2039/585 (EP,US); C12N2710/20034 (EP); C12N2760/10043 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/37]
TitleGerman:REPLIKATIONSDEFIZIENTE ARENAVIRUSPARTIKEL UND TRI-SEGMENTIERTE ARENAVIRUSPARTIKEL ALS KREBSIMPFSTOFFE[2019/37]
English:REPLICATION-DEFICIENT ARENAVIRUS PARTICLES AND TRI-SEGMENTED ARENAVIRUS PARTICLES AS CANCER VACCINES[2019/37]
French:PARTICULES D'ARÉNAVIRUS À DÉFICIENCE DE RÉPLICATION ET PARTICULES D'ARÉNAVIRUS TRI-SEGMENTÉES UTILISÉES COMME DE VACCINS CONTRE LE CANCER[2019/37]
Entry into regional phase24.04.2019National basic fee paid 
24.04.2019Designation fee(s) paid 
24.04.2019Examination fee paid 
Examination procedure24.04.2019Examination requested  [2019/37]
24.04.2019Date on which the examining division has become responsible
23.12.2019Amendment by applicant (claims and/or description)
10.07.2020Despatch of a communication from the examining division (Time limit: M06)
22.12.2020Reply to a communication from the examining division
08.02.2023Despatch of a communication from the examining division (Time limit: M04)
12.06.2023Reply to a communication from the examining division
Fees paidRenewal fee
26.11.2019Renewal fee patent year 03
20.11.2020Renewal fee patent year 04
24.11.2021Renewal fee patent year 05
24.11.2022Renewal fee patent year 06
24.11.2023Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inby applicantGB2220211
 US5057540
 WO2007109812
 WO2007109813
 WO2009083210
 WO2014140301
 WO2015082570
 WO2016075250
 WO2017EP61865
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.